CXCR4 antagonist plerixafor (AMD3100) combining with anti-PD-1 induced T-cell rapid accumulation among cancer cells and acted synergistically with α-PD-L1 to significantly decrease tumor volume 78. The gene discussed is CD274; the disease is cancer.